BP000027-CYT-336: Recombinant Mouse Vascular Endothelial Growth Factor (VEGF) Protein
Source: E. coli-derived.
The biological activity is determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-5.0 ng/ml corresponding to a specific activity of 0.2-1 MIU/mg.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.BP000027-CYT-577: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, Yeast
Source: Pichia Pastoris-derived.
Determined by its ability to stimulate 3H-Thymidine incorporation in human umbilical vein endothelial cells, the ED50 for this effect was found to be 2-6 ng/ml.
Purity: > 90% by SDS-PAGE.BP000027-CYT-619: Recombinant Human VEGF (121 a.a) Protein, His Tag
Source: E. coli-derived.
The ED50 for this effect is <4.2 ng/ml. Measured in a cell proliferation assay using NIH-3T3 cell, corresponding to a specific activity of less than 238,095 units/mg.
Purity: > 95% by SDS-PAGE.BP000027-CYT-680: Recombinant Mouse Vascular Endothelial Growth Factor (VEGF) Protein, His Tag
Source: E. coli-derived.
Measured in a cell proliferation assay using NIH-3T3 mouse embryonic fibroblast. The ED50 for this effect is 0.5-1.5 ng/ml.
Purity: >90% by SDS-PAGE.BP001432-PRO-563: Recombinant Human Growth Arrest and DNA-Damage-Inducible Beta (GADD45B) Protein
Source: E. coli-derived.
Purity: > 95.0% by SDS-PAGE.BP001433-PRO-570: Recombinant Human Growth arrest and DNA damage-inducible protein GADD45 gamma (GADD45G) Protein
Source: E. coli-derived.
Purity: > 95.0% by SDS-PAGE.BP001522-PRO-581: Recombinant Human High mobility group protein B1 (HMGB1) Protein
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP001522-PRO-610: Recombinant Human High mobility group protein B1 (HMGB1) Protein, Hi-5
Source: Hi-5 Insect Cells-derived.
Purity: > 90% by SDS-PAGE.BP001345-ENZ-631: Recombinant Human ADP-ribosylarginine hydrolase (ADPRH) Enzyme
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP001604-PRO-627: Recombinant Human BH3-interacting domain death agonist (BID) Protein
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.